Abaxis Falls After Downgrade On Piccolo Revenue
NEW YORK (AP) ¿ Shares of blood analysis systems company Abaxis Inc. fell Tuesday after a SunTrust Robinson Humphrey analyst downgraded the stock, pointing to weak sales of Abaxis' Piccolo xpress testing device.
Analyst Jonathan Block said sales of Piccolo systems "dropped precipitously" this year after Abaxis instituted a new sales strategy, and the company will probably need to close some large deals to reach Wall Street's expectations. If that does not happen, the stock price could drop, he said.
Block cut his rating on shares of the Union City, Calif., company to "Neutral" from "Buy," and trimmed his fiscal 2010 and 2011 profit estimates. He now expects the company to earn 70 cents per share for the year ending in March, down from 71 cents per share, and 90 cents per share the following year, down from 92 cents per share.
On average, Thomson Reuters says analysts expect 71 cents per share in 2010 and 89 cents per share in 2011. In morning trading, Abaxis stock slid $1.18, or 4.6 percent, to $24.41.Block said Abaxis' new veterinary products are selling well, and so are its chemistry analyzer products. However he said the stock price will not rise further until sales of the medical products improve. Abaxis shares have climbed 62 percent over the last year, and peaked at $29.80 on Sept. 17.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV